Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation
Completed · Phase 4
Conditions studied: Wound Infection
In brief
This is a prospective, randomized trial comparing the outcomes for Prontosan versus normal saline as the solution for negative pressure wound therapy with instillation (NWPTi). Negative pressure wound therapy (NPWT) is a well established method of treatment for acute and chronic wounds. The combination of negative pressure with instillation of a solution is a relatively novel concept that has gained popularity and is currently used nationally and internationally. NPWTi is the standard of care for our division. Despite the growing use, there is limited information regarding the selection of the ideal instillation solution. This is a single site, investigator initiated, NPWTi study comparing the use of Prontosan with normal saline for the adjunctive treatment of the acutely infected wound that requires hospital admission. A total of 100 subjects will be included with 50 subjects in each treatment arm. The outcomes that will be measured are 1) number of operations, 2) length of hospital stay, 3) % of wounds closed prior to discharge, 4) time to closure prior to discharge, 5)% remained closed at 30 day follow-up, and 6) reduction of qualitative bacterial cultures. The results from this study will better characterize the most appropriate use of NPWTi.
Key facts
- Study ID
- NCT01939145
- Run by
- Georgetown University
- People needed
- 100
- Starts
- 2013-09-01
- Expected to finish
- 2016-07-01
- Last updated by the study team
- 2016-12-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female greater than 18 years of age
- Admission to the hospital for an infected wound
- Diabetic, ischemic, neuropathic, venous, surgical wounds, any anatomical location
- Subjects requiring serial (more than 1) operative debridement
You may not qualify if…
- Pregnancy
- Patients with exposed bowel, brain matter, spinal cord
- Patients with exposed peripheral bypass grafts
- Known allergy or sensitivity to Prontosan or components of NPWT
- Known allergy or sensitivity to adhesives
- Uncontrolled bleeding disorders/coagulopathy
- Wounds that tunnel to unexposed areas
- Malignancy
Where it is running
- Medstar Georgetown University Hospital Center for Wound Healing — Washington D.C., District of Columbia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.